These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16126608)

  • 1. Genetic determinants of addiction to opioids and cocaine.
    Saxon AJ; Oreskovich MR; Brkanac Z
    Harv Rev Psychiatry; 2005; 13(4):218-32. PubMed ID: 16126608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of dopamine and its contribution to cocaine addiction.
    Haile CN; Kosten TR; Kosten TA
    Behav Genet; 2007 Jan; 37(1):119-45. PubMed ID: 17063402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine dependence.
    Weller AE; Dahl JP; Lohoff FW; Kampman KM; Oslin DW; Dackis C; Ferraro TN; O'Brien CP; Berrettini WH
    Psychiatr Genet; 2006 Oct; 16(5):193-6. PubMed ID: 16969273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine, dopamine and the endogenous opioid system.
    Kreek MJ
    J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review.
    Bauer IE; Soares JC; Nielsen DA
    Am J Addict; 2015 Jan; 24(1):15-23. PubMed ID: 25823631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence.
    Fernàndez-Castillo N; Roncero C; Grau-Lopez L; Barral C; Prat G; Rodriguez-Cintas L; Sánchez-Mora C; Gratacòs M; Ramos-Quiroga JA; Casas M; Ribasés M; Cormand B
    Genes Brain Behav; 2013 Feb; 12(1):39-46. PubMed ID: 23241418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of genetic variants of the dopaminergic system in heroin dependence].
    Vereczkei A; Sasvári-Székely M; Barta C
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):95-101. PubMed ID: 19827317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of dopamine receptors and drug addiction: a comprehensive review.
    Le Foll B; Gallo A; Le Strat Y; Lu L; Gorwood P
    Behav Pharmacol; 2009 Feb; 20(1):1-17. PubMed ID: 19179847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions.
    Brousse G; Vorspan F; Ksouda K; Bloch V; Peoc'h K; Laplanche JL; Mouly S; Schmidt J; Llorca PM; Lepine JP
    Med Hypotheses; 2010 Dec; 75(6):600-4. PubMed ID: 20801583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
    Crist RC; Ambrose-Lanci LM; Vaswani M; Clarke TK; Zeng A; Yuan C; Ferraro TN; Hakonarson H; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Doyle GA; Lohoff FW; Berrettini WH
    Drug Alcohol Depend; 2013 Jan; 127(1-3):122-8. PubMed ID: 22795689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
    Yuferov V; Levran O; Proudnikov D; Nielsen DA; Kreek MJ
    Ann N Y Acad Sci; 2010 Feb; 1187():184-207. PubMed ID: 20201854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.
    Dahl JP; Cubells JF; Ray R; Weller AE; Lohoff FW; Ferraro TN; Oslin DW; Kampman KM; Dackis C; Tang Y; Gelernter J; Kranzler HR; O'Brien CP; Berrettini WH
    Addict Biol; 2006 Mar; 11(1):76-83. PubMed ID: 16759340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence.
    Law PY; Loh HH; Wei LN
    Neuropharmacology; 2004; 47 Suppl 1():300-11. PubMed ID: 15464146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cocaine: historical background, neurobiology of the addiction and relapse and therapeutic perspectives].
    Silva MI; Citó MC; Vasconcelos PF; Vasconcelos SM; Sousa FC
    Acta Med Port; 2010; 23(2):247-58. PubMed ID: 20470473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
    Guo Y; Wang HL; Xiang XH; Zhao Y
    Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
    Kreek MJ; Levran O; Reed B; Schlussman SD; Zhou Y; Butelman ER
    J Clin Invest; 2012 Oct; 122(10):3387-93. PubMed ID: 23023708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.